Business Context and Reporting Period
Company: BiomX Inc. (PHGE)
Filing Type: Form 8-K (Current Report)
Date of Report: March 25, 2026
Reporting Period: Event-based report regarding listing compliance status.
Key Financial Metrics
This filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document references historical financial performance only to explain the basis for non-compliance with listing standards:
- Stockholders' Equity: The Company is not in compliance with NYSE American standards requiring minimum equity of $2.0 million, $4.0 million, or $6.0 million, depending on the number of consecutive fiscal years with reported losses.
- Loss History: The Company has reported losses from continuing operations and/or net losses in multiple recent fiscal years (specifically triggering thresholds for 2, 3, or 5 of the most recent years).
- Market Capitalization: The Company does not currently qualify for exemptions based on a total market capitalization exceeding $50 million.
Material Changes
Listing Status: On March 25, 2026, BiomX Inc. received a written notice from NYSE American indicating non-compliance with continued listing standards (Section 1003(a) of the Company Guide). This is a material change in the Company's regulatory standing regarding its exchange listing.
Outlook, Management Commentary, and Risks
- Compliance Plan Deadline: The Company must submit a plan to regain compliance to NYSE American by April 24, 2026.
- Compliance Target Date: The plan must demonstrate actions to regain compliance by September 25, 2027.
- Delisting Risk: If the Company fails to submit a plan, the plan is rejected, or the Company fails to make progress consistent with the plan by the target date, NYSE American will initiate delisting proceedings.
- Current Trading Status: The notice has no immediate effect on the listing or trading of Common Stock; trading continues under the symbol "PHGE" on NYSE American.
- Management Action: Management is reviewing options to address deficiencies and expects to submit a compliance plan by the deadline.
Investor Verification Checklist
- Verify the specific amount of stockholders' equity reported in the most recent 10-K or 10-Q to confirm the exact deficiency.
- Monitor the submission of the compliance plan by the April 24, 2026 deadline.
- Review the Company's historical loss records to determine which specific equity threshold ($2M, $4M, or $6M) applies.
- Check for any subsequent press releases or filings regarding the acceptance or rejection of the compliance plan by NYSE American.